Puma Biotechnology
PBYI
PBYI
115 hedge funds and large institutions have $2.49B invested in Puma Biotechnology in 2013 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
25% more funds holding
Funds holding: 92 → 115 (+23)
4.65% more ownership
Funds ownership: 79.19% → 83.84% (+4.7%)
10% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 41
Holders
115
Holding in Top 10
3
Calls
$7.69M
Puts
$4.39M
Top Buyers
| 1 | +$165M | |
| 2 | +$48.2M | |
| 3 | +$46M | |
| 4 |
CCI
Columbus Circle Investors
|
+$28.9M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$24.8M |
Top Sellers
| 1 | -$75.5M | |
| 2 | -$33.3M | |
| 3 | -$30.3M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$28.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$22.1M |